Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 1, 2012

Study Completion Date

January 16, 2012

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate

Fluticasone propionate inhalation powder, 250 µg

DRUG

Fluticasone furoate

Fluticasone furoate inhalation powder, 100 µg

DRUG

Placebo

Placebo inhalation powder

Trial Locations (82)

3120

GSK Investigational Site, Tremelo

3544

GSK Investigational Site, Halen

5360

GSK Investigational Site, Natoye

6534

GSK Investigational Site, Gozée

10367

GSK Investigational Site, Berlin

12043

GSK Investigational Site, Berlin

12157

GSK Investigational Site, Berlin

15241

GSK Investigational Site, Pittsburgh

15562

GSK Investigational Site, Rüdersdorf

16303

GSK Investigational Site, Schwedt

19426

GSK Investigational Site, Collegeville

21236

GSK Investigational Site, Baltimore

23225

GSK Investigational Site, Richmond

28152

GSK Investigational Site, Shelby

29118

GSK Investigational Site, Orangeburg

29607

GSK Investigational Site, Greenville

30173

GSK Investigational Site, Hanover

31707

GSK Investigational Site, Albany

31904

GSK Investigational Site, Columbus

32132

GSK Investigational Site, Edgewater

32806

GSK Investigational Site, Orlando

33155

GSK Investigational Site, Miami

33185

GSK Investigational Site, Miami

33189

GSK Investigational Site, Cutler Bay

35209

GSK Investigational Site, Birmingham

36106

GSK Investigational Site, Montgomery

37269

GSK Investigational Site, Eschwege

39112

GSK Investigational Site, Magdeburg

42301

GSK Investigational Site, Owensboro

44718

GSK Investigational Site, Canton

45005

GSK Investigational Site, Franklin

45359

GSK Investigational Site, Essen

45459

GSK Investigational Site, Dayton

62269

GSK Investigational Site, Shiloh

63141

GSK Investigational Site, St Louis

65203

GSK Investigational Site, Columbia

66215

GSK Investigational Site, Lenexa

70006

GSK Investigational Site, Metairie

70584

GSK Investigational Site, Sunset

72205

GSK Investigational Site, Little Rock

73103

GSK Investigational Site, Oklahoma City

75225

GSK Investigational Site, Dallas

76712

GSK Investigational Site, Waco

77054

GSK Investigational Site, Houston

78028

GSK Investigational Site, Kerrville

78224

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

78251

GSK Investigational Site, San Antonio

78750

GSK Investigational Site, Austin

85614

GSK Investigational Site, Green Valley

89119

GSK Investigational Site, Las Vegas

90274

GSK Investigational Site, Rolling Hills Estates

90808

GSK Investigational Site, Long Beach

90813

GSK Investigational Site, Long Beach

92024

GSK Investigational Site, Encinitas

92120

GSK Investigational Site, San Diego

92123

GSK Investigational Site, San Diego

92128

GSK Investigational Site, San Diego

92506

GSK Investigational Site, Riverside

92647

GSK Investigational Site, Huntington Beach

92663

GSK Investigational Site, Newport Beach

92868

GSK Investigational Site, Orange

93301

GSK Investigational Site, Bakersfield

93720

GSK Investigational Site, Fresno

95117

GSK Investigational Site, San Jose

97504

GSK Investigational Site, Medford

99084

GSK Investigational Site, Erfurt

700115

GSK Investigational Site, Iași

92103-8415

GSK Investigational Site, San Diego

68123-4303

GSK Investigational Site, Bellevue

04626

GSK Investigational Site, Schmölln

39-200

GSK Investigational Site, Dębica

25-751

GSK Investigational Site, Kielce

93-513

GSK Investigational Site, Lodz

81-741

GSK Investigational Site, Sopot

71-124

GSK Investigational Site, Szczecin

18-400

GSK Investigational Site, Łomża

020125

GSK Investigational Site, Bucharest

022102

GSK Investigational Site, Bucharest

041914

GSK Investigational Site, Bucharest

050042

GSK Investigational Site, Bucharest

050526

GSK Investigational Site, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01159912 - Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents | Biotech Hunter | Biotech Hunter